H.R. 9127
117th Congress
House
Mandating Exclusive Review of Individual Treatments (MERIT) Act
Official title: To amend title XVIII of the Social Security Act to clarify the use of the national coverage determination process under the Medicare program.
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 5, 2022
Referred to the Subcommittee on Health.
Oct 4, 2022
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 4, 2022
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Latest action
Referred to the Subcommittee on Health.
Plain-English summary
Mandating Exclusive Review of Individual Treatments (MERIT) Act
This bill specifies that coverage determinations for drugs and biologics under Medicare must be made with respect to each drug or biologic, rather than with respect to a class of drugs or biologics.
Bill text
1 version
- Introduced in House Formatted Text PDF Formatted XML
Committees of jurisdiction
3
Cite this page
U.S. Congress. (2026). H.R. 9127: Mandating Exclusive Review of Individual Treatments (MERIT) Act. 117th Congress. Open America. https://openamerica.io/bill/117-HR-9127/
"H.R. 9127: Mandating Exclusive Review of Individual Treatments (MERIT) Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-9127/.
H.R. 9127, 117th Cong. (2026), https://openamerica.io/bill/117-HR-9127/.
[H.R. 9127: Mandating Exclusive Review of Individual Treatments (MERIT) Act](https://openamerica.io/bill/117-HR-9127/)